Table 4 The spike or nucleocapsid protein specific T cell positive rate in kidney transplants recipients and healthy participants after second dose of inactivated vaccine.

From: Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination

 

KTRs

HPs

p-value

20 ± 5 days after 2nd dose

(n = 40)

(n = 48)

 

 Spike specific T cell positive (%)

7 (17.5)

23 (47.9)

0.006

 NP specific T cell positive (%)

11 (27.5)

23 (47.9)

0.050

45 ± 10 days after 2nd dose

(n = 20)

(n = 27)

 

 Spike specific T cell positive (%)

8 (40.0)

17 (63.0)

0.119

 NP specific T cell positive (%)

5 (25.0)

16 (59.3)

0.020

  1. Significant values are in bold.
  2. KTRs kidney transplants recipients, HPs healthy participants, S1 The S1 ___domain of the spike protein, RBD receptor binding ___domain, NP nucleocapsid protein.
Back to article page